InsidersTradesSigma
Fortress Biotech, Inc.: management transactions · United States · SEC (Form 4)
SEC:fortress-biotech-inc-a706e5US·SEC (Form 4)Mcap 84M€Healthcare
Browse the full management transaction log of Fortress Biotech, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Fortress Biotech, Inc. has logged 9 reports. Market capitalisation: €84.3m. The latest transaction was filed on 29 April 2022 — Attribution. Among the most active insiders: WEISS MICHAEL S. Every trade is accessible without an account.
9
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€75,539
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.54 €
Analyst consensus
2 analysts4.50 €Target 10.75 €(+324%)17.00 €
Income statement
Revenue63.3 M€
Gross profit42.3 M€67% margin
Net income−1.9 M€10.8% margin
Valuation
PER (trailing)0.8x
P/Book1.6x
Beta1.16
Balance sheet & cash
Market cap84.3 M€
Total debt74.3 M€
Free Cash Flow−65.8 M€
Debt / Equity108%
Profitability & ownership
ROE-108.7%
ROA-26.6%
% insiders22.8%
% institutions18.2%
Last declaration on 29 April 2022
Declarations9 total
Executives◆Grant5SEC
01,102,986 shares0
Common Stock
SEC:0001104659-22-053619:0·
Executives◆Grant14SEC
0100,000 shares0
COMMON STOCK, PAR VALUE $0.001
SEC:0001104659-22-053580:0·
Executives◆Grant14SEC
0100,000 shares0
Common Stock, par value $0.001
SEC:0001104659-22-053578:0·
Executives▼Sale36SEC
€75,53928,292 shares@ €2.670.090% mcap100.0% of flow
Common Stock, par value $0.001
SEC:0001104659-22-053623:0·
Executives◆Grant14SEC
050,000 shares0
COMMON STOCK, PAR VALUE $0.001
SEC:0001104659-22-053584:0·
Executives◆Grant14SEC
0100,000 shares0
Common Stock, par value $0.001
SEC:0001104659-22-053572:0·
Executives◆Grant33SEC
€2,4521,297 shares@ €1.89070.0029% mcap100.0% of flow
COMMON STOCK, PAR VALUE $0.001
SEC:0001104659-22-053615:0·
9 of 9 declarations